Corporate Profile

Aeterna Zentaris Inc. (TSX: AEZ, NASDAQ: AEZS) is a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology. The Company's pipeline encompasses compounds at various stages of development.

Video : David Dodd, President and CEO

Contact us:

Aeterna Zentaris Inc.
1405 du Parc-Technologique Blvd.
Québec, Québec
Canada
G1P 4P5
Phone: (418) 652-8525
Fax: (418) 948-9191
www.aezsinc.com





Aeterna Zentaris: Poster Presentation at AACR Meeting Provides Rationale for New Therapeutic Opportunities in Oncology with Erk Inhibitors more...>

Aeterna Zentaris to Present Poster on New Therapeutic Opportunities in Oncology with Erk Inhibitors at AACR Meeting in San Diego more...>

Aeterna Zentaris Announces Effectiveness of $50 Million Shelf Registration Statement for “At-the-Market” Common Share Issuance Programs more...>
May 9, 2014
Annual shareholder meeting

More

 
Download PDF (67K)
Download and install Acrobat Reader